Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.67M Sell
242,791
-12,677
-5% -$160K 0.01% 281
2026
Q1
$3.83M Sell
255,468
-3,565
-1% -$52.1K 0.02% 281
2025
Q4
$3.37M Buy
259,033
+54,601
+27% +$798K 0.02% 286
2025
Q3
$3.27M Sell
204,432
-55,185
-21% -$908K 0.02% 292
2025
Q2
$3.89M Buy
259,617
+924
+0.4% +$13.5K 0.02% 282
2025
Q1
$3.88M Sell
258,693
-7,093
-3% -$105K 0.02% 287
2024
Q4
$3.72M Sell
265,786
-1,445
-0.5% -$25.8K 0.02% 294
2024
Q3
$5.34M Buy
267,231
+132,333
+98% +$2.39M 0.02% 271
2024
Q2
$2.29M Sell
134,898
-127,311
-49% -$2.35M 0.01% 305
2024
Q1
$4.46M Buy
+262,209
New +$3.98M 0.02% 297

Other funds holding HCM

M&G plc's HCM Position: Q2 2026 in Review

M&G plc reduced its HUTCHMED (HCM) stake by 5% in Q2 2026, selling an estimated $160K and leaving 242,791 shares worth $2.67M. The position accounts for 0.01% of the portfolio, ranked #281.

M&G plc first reported a position in HCM in Q1 2024 and has held it in 10 quarters since. The position peaked at $5.34M in Q3 2024. 56 funds tracked by Wall St. Rank hold HCM as of Q2 2026.

  • M&G plc held 242,791 shares of HUTCHMED worth $2.67M as of Q2 2026.
  • M&G plc sold 12,677 HUTCHMED shares in Q2 2026, an estimated $160K.
  • HUTCHMED made up 0.01% of M&G plc's portfolio in Q2 2026, its #281 holding.
  • M&G plc first reported a position in HUTCHMED in Q1 2024 and has held it in 10 quarters since.
  • M&G plc's HUTCHMED position peaked at $5.34M in Q3 2024.
  • 56 funds tracked by Wall St. Rank held HUTCHMED as of Q2 2026.

Based on M&G plc's 13F filing for Q2 2026, filed 6 Aug 2026.